BIODESIX, INC. Retained Earnings
BIODESIX, INC. (BDSX) had Retained Earnings of -$512.83 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$512.83M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$505.56M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$497.76M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$493.78M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$512.83M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$505.56M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | -$497.76M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | -$493.78M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | -$485.07M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$473.60M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$462.50M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$454.25M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | -$443.99M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$433.18M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$419.57M 10-K · filed 2025-03-03 | |
| 2023-09-30 | -$410.43M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$399.48M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$386.12M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$367.42M 10-K · filed 2024-03-01 | |
| 2022-09-30 | -$347.08M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$333.38M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$317.56M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$301.97M 10-K · filed 2023-03-06 | |
| 2021-09-30 | -$288.69M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$277.18M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$265.77M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | -$258.81M 10-K · filed 2022-03-14 | |
| 2020-09-30 | -$257.68M 10-Q · filed 2020-12-10 | |
| 2019-12-31 | -$227.46M 10-K · filed 2021-03-16 | -$230.86M 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |